Certain GLP-1 weight loss medications will be available for as little as $149 per month, a sharp drop from the current ...
The Trump administration announced deals on Thursday with pharmaceutical giants Novo Nordisk and Eli Lilly that would lower ...
Numerous recalls have been issued this year due to the potential for damaged products and undeclared food allergens.
The U.S. Food and Drug Administration said on Thursday it has awarded six more companies, including Eli Lilly and Novo ...
19hOpinion
The FDA’s Meltdown Escalates
An ethics complaint leads to a resignation, and the agency shifts approval standards.
Texas Attorney General Ken Paxton has asked a federal judge to force the makers of Tylenol to stop any advertising that the ...
The deal is with drugmakers Eli Lilly and Novo Nordisk to cut prices of their weight-loss drugs and expand Medicare coverage ...
Certain blockbuster obesity drugs will be available for as little as $149 per month and more Medicare enrollees will have ...
Trump announces deal with Eli Lilly, Novo Nordisk to lower cost of GLP-1 weight loss drugs Wegovy, Zepbound. Here's what to ...
Eli Lilly expects the U.S. Food and Drug Administration to approve its experimental oral obesity drug, orforglipron, by March ...
() -Rhythm Pharmaceuticals said on Friday the U. Food and Drug Administration has extended the review period for ...
Novo Nordisk and Eli Lilly said they've agreed to sell their blockbuster drugs Wegovy and Zepbound at a discount.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback